
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Julia Hippisley‐Cox, Pui San Tan, Carol Coupland
Heart (2020) Vol. 107, Iss. 2, pp. 170.2-171
Open Access | Times Cited: 43
Julia Hippisley‐Cox, Pui San Tan, Carol Coupland
Heart (2020) Vol. 107, Iss. 2, pp. 170.2-171
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Risk factors for hospitalization among persons with COVID-19—Colorado
Grace M. Vahey, Emily G. McDonald, Kristen E. Marshall, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256917-e0256917
Open Access | Times Cited: 57
Grace M. Vahey, Emily G. McDonald, Kristen E. Marshall, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256917-e0256917
Open Access | Times Cited: 57
The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review
Mahmoud Yousef, Mlaak Rob, Sanish Varghese, et al.
Life Sciences (2024) Vol. 342, pp. 122535-122535
Open Access | Times Cited: 7
Mahmoud Yousef, Mlaak Rob, Sanish Varghese, et al.
Life Sciences (2024) Vol. 342, pp. 122535-122535
Open Access | Times Cited: 7
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic
Dimitriοs Vlachakis, Eleni Papakonstantinou, Τhanasis Mitsis, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111805-111805
Open Access | Times Cited: 37
Dimitriοs Vlachakis, Eleni Papakonstantinou, Τhanasis Mitsis, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111805-111805
Open Access | Times Cited: 37
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
(2020)
Open Access | Times Cited: 32
David Simons, Lion Shahab, Jamie Brown, et al.
(2020)
Open Access | Times Cited: 32
Tobacco use disorder and the lungs
Hayden McRobbie, Benjamin C. H. Kwan
Addiction (2020) Vol. 116, Iss. 9, pp. 2559-2571
Closed Access | Times Cited: 21
Hayden McRobbie, Benjamin C. H. Kwan
Addiction (2020) Vol. 116, Iss. 9, pp. 2559-2571
Closed Access | Times Cited: 21
Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia
Petr Glybochko, В. В. Фомин, Sergey Moiseev, et al.
Clinical pharmacology and therapy (2020) Vol. 29, Iss. 3, pp. 25-36
Open Access | Times Cited: 19
Petr Glybochko, В. В. Фомин, Sergey Moiseev, et al.
Clinical pharmacology and therapy (2020) Vol. 29, Iss. 3, pp. 25-36
Open Access | Times Cited: 19
The Psychological Impact of Hypertension During COVID-19 Restrictions: Retrospective Case-Control Study
Carissa Bonner, Erin Cvejic, Julie Ayre, et al.
JMIRx Med (2021) Vol. 2, Iss. 1, pp. e25610-e25610
Open Access | Times Cited: 18
Carissa Bonner, Erin Cvejic, Julie Ayre, et al.
JMIRx Med (2021) Vol. 2, Iss. 1, pp. e25610-e25610
Open Access | Times Cited: 18
Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis
Piotr Tylicki, Karolina Polewska, Aleksander Och, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 451-451
Open Access | Times Cited: 8
Piotr Tylicki, Karolina Polewska, Aleksander Och, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 451-451
Open Access | Times Cited: 8
Use of drugs for hypertension or heart failure and the risk of death in COVID-19: association with loop-diuretics
Johan Fastbom, Gudrun Jonasdottir, Johanna Holm, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 10, pp. 1515-1522
Open Access | Times Cited: 1
Johan Fastbom, Gudrun Jonasdottir, Johanna Holm, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 10, pp. 1515-1522
Open Access | Times Cited: 1
Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
Meichen Yan, Yuan Dong, Xuena Bo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 8
Meichen Yan, Yuan Dong, Xuena Bo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 8
Cardiovascular Complications of COVID-19 Infection
Maria Trêpa, Antonio Hipólito Reis, Mário Oliveira
Acta Médica Portuguesa (2021) Vol. 34, Iss. 9, pp. 608-614
Open Access | Times Cited: 7
Maria Trêpa, Antonio Hipólito Reis, Mário Oliveira
Acta Médica Portuguesa (2021) Vol. 34, Iss. 9, pp. 608-614
Open Access | Times Cited: 7
Outcomes of Heart Failure in COVID-19 Patients: An Appalachian Experience
Huzefa Bhopalwala, Aelia Akbar, Nakeya Dewaswala, et al.
Cardiology Research (2022) Vol. 13, Iss. 3, pp. 162-171
Open Access | Times Cited: 4
Huzefa Bhopalwala, Aelia Akbar, Nakeya Dewaswala, et al.
Cardiology Research (2022) Vol. 13, Iss. 3, pp. 162-171
Open Access | Times Cited: 4
The GRACE risk score in patients with ST-segment elevation myocardial infarction and concomitant COVID-19
Mariusz Wójcik, Jakub Karpiak, Lech Zaręba, et al.
Archives of Medical Science - Atherosclerotic Diseases (2022) Vol. 7, Iss. 1, pp. 116-123
Open Access | Times Cited: 4
Mariusz Wójcik, Jakub Karpiak, Lech Zaręba, et al.
Archives of Medical Science - Atherosclerotic Diseases (2022) Vol. 7, Iss. 1, pp. 116-123
Open Access | Times Cited: 4
Risk factors and characteristics of hospitalized COVID-19 patients in Jordan
Rashed O. Alqaisi, Waqar Al-Kubaisy, Shahed N. S. Abughanam, et al.
Saudi Medical Journal (2023) Vol. 44, Iss. 10, pp. 1054-1060
Open Access | Times Cited: 2
Rashed O. Alqaisi, Waqar Al-Kubaisy, Shahed N. S. Abughanam, et al.
Saudi Medical Journal (2023) Vol. 44, Iss. 10, pp. 1054-1060
Open Access | Times Cited: 2
The cardiovascular complications in COVID-19 infection: Focus on acute cardiac injury
Sahrai Saeed, Ronak Rajani
Pakistan Journal of Medical Sciences (2021) Vol. 37, Iss. 3
Open Access | Times Cited: 5
Sahrai Saeed, Ronak Rajani
Pakistan Journal of Medical Sciences (2021) Vol. 37, Iss. 3
Open Access | Times Cited: 5
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
Jie Xu, Wenwei Xiao, Xuan Liang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 4
Jie Xu, Wenwei Xiao, Xuan Liang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 4
Using primary care databases for addiction research: An introduction and overview of strengths and weaknesses
Daniel Kotz, Amy O’Donnell, Sterling McPherson, et al.
Addictive Behaviors Reports (2022) Vol. 15, pp. 100407-100407
Open Access | Times Cited: 3
Daniel Kotz, Amy O’Donnell, Sterling McPherson, et al.
Addictive Behaviors Reports (2022) Vol. 15, pp. 100407-100407
Open Access | Times Cited: 3
Angiotensin converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists and SARS-CoV-2 infection
Pratiksha Valera, Pheletso Letuka, Nontobeko Mathenjwa, et al.
SA Heart (2020) Vol. 17, Iss. 3
Open Access | Times Cited: 3
Pratiksha Valera, Pheletso Letuka, Nontobeko Mathenjwa, et al.
SA Heart (2020) Vol. 17, Iss. 3
Open Access | Times Cited: 3
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 8)
David Simons, Lion Shahab, Jamie Brown, et al.
(2020)
Open Access | Times Cited: 3
David Simons, Lion Shahab, Jamie Brown, et al.
(2020)
Open Access | Times Cited: 3
Respiratory disorders and their association with clinical outcomes in COVID-19: a narrative review of current literature
Divya Venkat, M. Safwan Badr
Annals of Palliative Medicine (2023) Vol. 12, Iss. 6, pp. 1232-1243
Open Access | Times Cited: 1
Divya Venkat, M. Safwan Badr
Annals of Palliative Medicine (2023) Vol. 12, Iss. 6, pp. 1232-1243
Open Access | Times Cited: 1
Are Patients With Diabetes Mellitus at Increased Risk of COVID-19 Infection
Mehmet Sözen, Fatma Çölkesen, Şevket Arslan, et al.
Archives of Current Medical Research (2021) Vol. 2, Iss. 1, pp. 38-44
Open Access | Times Cited: 2
Mehmet Sözen, Fatma Çölkesen, Şevket Arslan, et al.
Archives of Current Medical Research (2021) Vol. 2, Iss. 1, pp. 38-44
Open Access | Times Cited: 2
Tailored Dietary Plan to Sustain Healthy Lifestyle of Adults with Restrained Mobility
Jomana Khawandanah
Food Science & Nutrition Technology (2022) Vol. 7, Iss. 2, pp. 1-16
Open Access | Times Cited: 1
Jomana Khawandanah
Food Science & Nutrition Technology (2022) Vol. 7, Iss. 2, pp. 1-16
Open Access | Times Cited: 1
Anastasiia Zykova, Pavel Novikov, Michail Brovko, et al.
Clinical pharmacology and therapy (2020) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Renin Angiotensin System and Covid-19 Infection
Francesco Ferrara, Antonio Vitiello
Advanced Pharmaceutical Bulletin (2021)
Open Access | Times Cited: 1
Francesco Ferrara, Antonio Vitiello
Advanced Pharmaceutical Bulletin (2021)
Open Access | Times Cited: 1
Journalists with undisclosed conflicts mispresent research on COVID-19, confuse it with tobacco harm reduction and make false allegations about conflicts in a BMJ article
Konstantinos Farsalinos
(2021)
Open Access | Times Cited: 1
Konstantinos Farsalinos
(2021)
Open Access | Times Cited: 1